Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - OTHER CURRENT LIABILITIES
Other Current Liabilities RARE - Ultragenyx Pharmaceutical Inc.
226 M
LAST VALUE
29.55%
2 YEAR CAGR
29.30%
5 YEAR CAGR
47.98%
10 YEAR CAGR